ACBD5 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 6.672500E-02 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.865020E-01 |
Normal-vs-Stage2 |
5.960300E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.168800E-01 |
Stage1-vs-Stage2 |
1.929610E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.749400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.434220E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.953900E-02 |
Normal-vs-AfricanAmerican |
6.382500E-03 |
Normal-vs-Asian |
2.310000E-01 |
Caucasian-vs-AfricanAmerican |
3.545000E-01 |
Caucasian-vs-Asian |
8.352800E-01 |
AfricanAmerican-vs-Asian |
9.489600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.204400E-01 |
Normal-vs-Female |
3.254300E-02 |
Male-vs-Female |
1.343840E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.950800E-01 |
Normal-vs-Extreme_Weight |
1.146400E-01 |
Normal-vs-Obese |
1.814200E-01 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.201200E-01 |
Normal_Weight-vs-Obese |
7.212000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
9.664600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.779400E-04 |
Normal-vs-Age(41-60Yrs) |
3.107200E-01 |
Normal-vs-Age(61-80Yrs) |
2.833000E-01 |
Normal-vs-Age(81-100Yrs) |
1.379580E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.601400E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.467700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.303000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.905800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.835960E-04 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.059800E-03 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.546200E-01 |
Normal-vs-Grade 3 |
5.225000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.670000E-02 |
Grade 2-vs-Grade 4 |
9.546200E-01 |
Grade 3-vs-Grade 4 |
5.225000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.675830E-01 |
Normal-vs-N1 |
2.857800E-01 |
N0-vs-N1 |
8.943600E-01 |
|
|